# Response To Oral Agents in Diabetes (ROAD)- Pilot Study

> **NCT00780715** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 29 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Gliclazide MR
- **DRUG:** Sitagliptin
- **DRUG:** Pioglitazone
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00780715
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780715, "Response To Oral Agents in Diabetes (ROAD)- Pilot Study". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00780715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*